Infection Prevention and Containment Conference 2016: Speakers
To get the latest updates, please sign up for the IPCC 2016 newsletter.
To get the latest updates, please sign up for the IPCC 2016 newsletter.
National lead for HCAI and IPC within Public Health England and Chairman of the IPCC 2016
Susie’s’ career in the health service spans over 30 years, she initially specialised in orthopaedics and trauma. She moved into the field of Infection prevention and control in the 1990s and undertook further qualifications in Infection Control and HIV and AIDs management. She has held various roles throughout her career and in numerous differing settings including the acute, community, District Health Authority and Non Departmental Government Agency organisations. With over 25 years’ experience in Public Health and Health protection, she has contributed to the rolling out of the Men C vaccine programme, implementing HCAI and Infection Prevention and Control initiatives, Control of Foot and Mouth disease in the rural areas, numerous chemical fires, contaminated land incidents and meningitis and TB outbreaks as well as leadership and commissioning experiences. Her current role is as a national lead for HCAI and IPC within Public Health England, has a remit of providing national and international advice on IPC and HCAI and translating strategy into operational delivery.
Head of the Department of Healthcare-associated Infections and Antimicrobial Resistance at the National Infection Service, Public Health England
TOPIC: Keynote: The loss of antibiotics and its future impact on hospitals and the prevention of HCAIs
Professor Alan Johnson has worked in the field of antimicrobial resistance for over 25 years and was previously based in the national Antibiotic Resistance Monitoring and Reference Laboratory before moving to his current post in 2006. He is the PHE Lead for the NIHR Health Protection Research Unit (HPRU) in Healthcare-associated Infections and Antimicrobial Resistance at Imperial College London, and is a co-theme lead for the HPRU data linkage workstreams at both Imperial College and the University of Oxford. He is also a member of the government Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infection (ARHAI).
Consultant Medical Microbiologist, Public Health Laboratory, London, Public Health England
TOPIC: The New National Quality Standard for Healthcare Associated Infection (QS113)
Dr. Patel has advised many NHS Trusts on the management of healthcare associated infections and antimicrobial resistance. As consultant clinical adviser for the National Institute for Health and Clinical Excellence (NICE) he was co-organiser for prevention and control of healthcare-associated infections (PH36), producing quality improvement statements, which provide clear markers of excellence in infection prevention and control, and more recently a specialist committee member producing NICE quality standards [QS113] for HAIs. He chaired the Pseudomonas aeruginosa Working group (PAW) for the then Health Protection Agency providing expect advice on water systems in relation to neonatal deaths in Northern Ireland. Dr. Patel has served on several health regulator review panels: Regulation and Quality Improvement Authority (RQIA), Northern Ireland and Healthcare Inspectorate for Wales (HIW), investigating outbreaks of Clostridium difficile in acute hospitals and Health Information & Quality Authority, Ireland maternal death inquiry and more recently a neonatal deaths inquiry for HIW. He has served on many guidance development working groups and is currently a member of the toxigenic Staphylococcus aureus guidance development team. He is the author of ‘The good practice guide to control Clostridium difficile’, which was used by many trusts and PCTs.
Professor of Pharmaceutical Microbiology at the Cardiff School of Pharmacy & Pharmaceutical Sciences (Cardiff University, Wales)
TOPIC: Consumables – Disinfectants, Wipes, Sprays: Ensuring your cleaning regime is effective – New guidance and best practice
Professor Jean-Yves Maillard’s field of expertise concerns biocides; their activity, mechanisms of action, and the emergence of microbial resistance and cross-resistance to antimicrobials. He has a particular interest in antimicrobial wipes and efficacy test protocols. He is the recipient of the FEMS Fellowship award (1998), the WH Pierce Memorial prize (2004), the British Pharmaceutical Conference Science Medal (2004), the AD Russell Memorial Lecture Prize (2012), the Cardiff University Innovation and Engagement 2015 award in the categories Business and Innovation and People Choice and Insider’s Business and Education Partnerships 2015 Award in the category Research and Development. He has published over 130 peer-reviewed articles, 19 book chapters and 3 books and over 110 refereed conference communications. He is also working as a consultant for the industry and as an independent expert for the European Commission on matters related to bacterial resistance and cross-resistance to microbicides. He is the Chief Editor of Letters in Applied Microbiology and a member of the editorial board for the Journal of Antimicrobial Chemotherapy.
Industrial Design (Engineering) BA (Hons), Design Development Director at Renfrew Group international
TOPIC: Re-engineering isolation in rooms to prevent the spread of HCAIs
Michael qualified in Industrial design at Central St Martins in 1985 and has worked since within consultancies and industry in automotive, aerospace, consumer and medical technology sectors. His extensive experience led to problem solving and equipment design for public sector organisations, including the Department of Health, NHS National Innovation Centre and NHS nationally, leading on innovation in medical technology programmes. He has designed and provided innovation consultancy for clients including Airbus, GSK, ThermoFisher, Raleigh, Honda, Aprilia, Xerox, Shell, Iveco, Countax, NHS and UK Sport. Developer of intellectual property and author of patents. Projects in USA, EU, South America and S.E. Asia.
Lead Practitioner for Infection Prevention and Control,Forensic Services Nottinghamshire Healthcare NHS Foundation Trust
TOPIC: Cleaning Regimes – Shared insights for improved cleaning & implementation of Epic3* in challenging environments
*National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England.
Pixy has been with the trust since 2009 and has progressed to the role of the Lead Practitioner for Infection Prevention and Control, Forensic Services. She spent eight years in acute surgical nursing while supporting the Infection Prevention and Control team in Guildford and Doncaster where she completed an Infection Prevention and Control foundation course at the University of Sheffield. She holds a Graduate Certificate in IPC and a BA(Hons) Health and Social Care practice, having worked in one high secure, two medium secure and one low secure hospitals and 14 prisons while at the Forensic Mental Health and Offender Health.
TOPIC: Garments and their use in controlling microbiological contamination
Simon graduated from Selwyn College Cambridge in 1985 with a degree in Electrical Sciences. Having worked in his family’s laundry business from a teenager, he took over from his father as Managing Director in 1993. He moved to the Chairman role in 2013 to allow himself the time to focus on the strategic development of the business. Micronclean is UKs leading supplier of garment rental services to the cleanroom sector and the company has gained specific knowledge in the use of garments to contain and control microbiological contamination and in the decontamination of these garments after use. Simon is also a director of the laundry industry’s trade association, the TSA, and in that capacity is attempting to establish a two year KTP with De Montfort University to look at the role of hospital uniforms in the control of HAIs.
Life Sciences Product Innovation and Regulation Director, Water Conditioning Services UK , SUEZ
TOPIC: Understanding and effectively managing water systems, with specific reference to Legionella and Pseudomonas
Richard is an active member of the British Association of Chemical Specialities (BACS), MediLinks and works closely with institutions, governments and regulatory bodies throughout the world. This has included advising the Health & Safety Executive (HSE ) on the new L8 technical guidance, collaborating with the Health & Safety Laboratory (HSL), HSE and Chemicals Regulation Directorate (CRD) on Biocidal Products Regulations and having contributed towards the Department of Health Growth Priorities for Health and Social Care and the Accelerated Access Review. He has presented papers on microbial control, life sciences and water treatment throughout the world and is cited as inventor on several international patents. Richard graduated in Microbiology and Genetics at Swansea University, UK.